Investor directory

Angelo Gordon

Angelo Gordon is a privately-held registered investment advisor established in 1988, specializing in alternative investments. The firm manages approximately $36 billion and is dedicated to generating absolute returns with low volatility by identifying inefficiencies in selected markets and pursuing unique investment opportunities. Angelo Gordon offers a diverse array of absolute return strategies tailored for both institutional and high net worth clients. The firm’s success is attributed to its extensive research, a talented team, and a risk-averse investment philosophy that has consistently delivered positive results across various market conditions. With decades of experience, Angelo Gordon is committed to transforming its insights and strategies into profitable and stable business ventures.
http://www.angelogordon.com
https://crunchbase.com/organization/angelo-gordon-co
https://linkedin.com/company/angelo-gordon-&-co-
https://twitter.com/angelo_gordon
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=1689088
https://www.privateequityinternational.com/database/#/profile?id=5225

Robert Barrett

MD of Energy

Josh Baumgarten

Co-CEO and Co-CIO

Colleen Casey

MD

Steven Cha

Managing Director and Co-Portfolio Manager

EK Choi

Director of Asia Real Estate

Tracy DeBlieck

Director of Europe Real Estate

Michael Diana

MD of Europe Real Estate

Todd Dittmann

Head of Energy

Stefan Doerffler

Director of Europe Real Estate

Thomas Durkin

MD, Co-Head of Structured Credit, Portfolio Manager, Head of Residential & Consumer Debt

Julien Farre

MD of Distressed and Corporate Special Situations

Noreen Feldmann

Managing Director

Rick Finger

MD of Commercial Real Estate Debt

Bryce Fraser

MD, Distressed and Corporate Special Situations

Thomas M. Fuller

MD

Lauren Gallagher

Director of Performing Credit

Ben Gearing

Director of Distressed and Corporate Special Situations

Peter C. Gingold

MD of Performing Credit

Ruth Gitlin

Managing Director

Michael Gordon

Chief Executive Officer and Chief Investment Officer

Scott Greenfield

MD of Commercial Real Estate Debt

Jena Hines

Director of Commercial Real Estate Debt

Zhiqin Huang

Director

Christina Hwang

MD of Performing Credit

Abhinav Jain

Associate

Yong Joe

MD & Co-Portfolio Manager of Residential and Consumer Debt

David W. Kamin

MD of Multi Strategy & Portfolio Manager

Samir Khiroya

Director of Liquid Credit

Sharon Kay Kilmer

MD of Net Lease Real Estate

Chris Kim

MD of Asia Real Estate

Noah Kraff

Associate

Edward Kressler

MD of Performing Credit

Ken Kuga

Managing Director, Investor Relations

Joseph Z. Lenz

MD of Distressed and Corporate Special Situations

Wilson Leung

Managing Director and Head of Real Estate

Michael Lewin

Director of Commercial Real Estate Debt

Paul Lewis

Director

Reid Liffmann

Managing Director

Ethan Lin

Director of Asia Real Estate

Damien Loveday

Managing Director

Christina Lyndon

MD of U.S. Real Estate

Mark Maduras

Managing Director and Head of Finance

Ronald A. Malone

Senior Advisor

Marianne Manzolillo

MD of Performing Credit

D. Scott McMurtry

MD of Energy

Anuj Mittal

Managing Director and Co-Portfolio Manager of European Real Estate

Jenny Morton

Managing Director and Head of Global Consultant Relations

Harish Nataraj

MD

Ken Ng

Head of Real Estate and Managing Director

Christopher Oka

MD of U.S. Real Estate

Sven M. Olson

Director of Performing Credit

Aaron Ong

MD

John O’Meara

MD, Distressed and Corporate Special Situations

Steven Paget

Managing Director and Portfolio Manager for European Performing Credit

W. Fort Parker

MD

Bhavit Patel

Managing Director, Investor Relations

Arthur Peponis

Head of Private Equity and Special Situations

Damon B. Putman

MD of Energy

David Roberts

Senior Managing Director and Head of Strategy

Andrew Rowland

Director of Distressed and Corporate Special Situations

Bryan Rush

MD, Distressed and Corporate Special Situations

Adam Schwartz

Co-CEO and Co-CIO

Aliana Spungen

Managing Director

Frank Emil Stadelmaier

Chief Operating Officer

Jon Tanaka

Head of Real Estate and Managing Director

Donhoa Tran

MD of Performing Credit

Garrett A. Walls

Global Head of Investor Relations

Louise Wasso

Managing Director and Global Head of Private Wealth and Middle Market Group

Kirk Wickman

President

Mark Wojtusiak

MD

Gary Isaac Wolf

MD & Head of Convertible Arbitrage

Adam Wueger

Director of Performing Credit

Lisa Yahr

Managing Director

Tetsu Yaoka

MD of Asia Real Estate

Zoe Zuo

MD of Asia Real Estate

1 past transactions

Revlon

Private Equity Round in 2023
Revlon, Inc. is a global provider of beauty and personal care products, encompassing a diverse portfolio that includes cosmetics, hair color, fragrances, and skincare items. The company operates through several segments: Revlon, Elizabeth Arden, Portfolio, and Fragrances. The Revlon segment focuses on color cosmetics and beauty tools, while Elizabeth Arden offers skincare and fragrances. The Portfolio segment features brands such as Almay and American Crew, along with various nail care products. Additionally, Revlon develops and distributes owned and licensed fragrances under numerous well-known labels. Founded in 1932, Revlon markets its products primarily through mass merchandisers and drugstores across North America, EMEA, Asia, Latin America, and the Pacific, with North America being the largest revenue source. The company's commitment to quality and innovation has established it as a significant player in the cosmetics industry.